Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

BACKGROUND: Single-agent gemcitabine (GEM) is a standard treatment for advanced and metastatic pancreatic cancer. This study examines the question whether GEM-based combination chemotherapy can further improve treatment efficacy. METHODS: A meta-analysis was performed to evaluate randomized trials c...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292732/
https://www.ncbi.nlm.nih.gov/pubmed/18373843
http://dx.doi.org/10.1186/1471-2407-8-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292732/
https://www.ncbi.nlm.nih.gov/pubmed/18373843
http://dx.doi.org/10.1186/1471-2407-8-82

Ejemplares similares